Solid Biosciences Inc. ($SLDB)
Filing Information
| Accession Number | 0001193125-26-034089 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 3, 2026 |
| Document Date | Jan 29, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
486,779
Total Value
$172,747.09
P&L
+inf% (+$1,997,160.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CFO & Treasurer | Common Stock | โ | Jan 29, 2026 | Exercise/Conversion | 56,646 | โ | โ | 102,746 | Direct | โ | View Details | |
CFO & Treasurer | Common Stock | โ | Jan 31, 2026 | Exercise/Conversion | 33,075 | โ | โ | 135,821 | Direct | โ | View Details | |
CFO & Treasurer | Common Stock | โ | Feb 2, 2026 | Sale | 26,837 | $6.44 | $172,747.09 | 108,984 | Direct | โ | View Details | |
CFO & Treasurer | Performance Stock Units | Derivative | Jan 29, 2026 | Exercise/Conversion | 56,646 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
CFO & Treasurer | Employee Stock Option (Right to Buy) | Derivative | Jan 29, 2026 | Grant/Award | 187,000 | $0.00 | $0.00 | 187,000 | Direct | โ | View Details | |
CFO & Treasurer | Restricted Stock Units | Derivative | Jan 29, 2026 | Grant/Award | 93,500 | $0.00 | $0.00 | 93,500 | Direct | โ | View Details | |
CFO & Treasurer | Restricted Stock Units | Derivative | Jan 31, 2026 | Exercise/Conversion | 33,075 | $0.00 | $0.00 | 99,225 | Direct | โ | View Details |